Devendra, a farmer from India, recalls the moment a snake bit him while he was foraging for mulberry leaves. He delayed seeking help, which resulted in the amputation of his leg due to complications from the snakebite.

Every year, around 50,000 Indians die from snakebites, accounting for nearly half of the global fatalities. Some estimates indicate that from 2000 to 2019, as many as 1.2 million deaths may have occurred in India due to snakebites.

A recent study conducted by the Global Snakebite Taskforce (GST) indicates significant challenges for medical professionals in India, with 99% of them reporting difficulties in providing antivenom. The survey highlighted that the predominant barriers include insufficient infrastructure and inadequate training.

Half of the healthcare professionals stated that delays in treatment often led to severe complications in patients, including amputations and chronic mobility issues.

The World Health Organization (WHO) identified snakebite envenoming as a neglected tropical disease, as it disproportionately impacts vulnerable communities in rural areas, particularly in low and middle-income countries.

In 2024, India introduced the National Action Plan for Prevention and Control of Snakebite Envenoming (NAPSE) with the goal to reduce deaths by half by 2030. This initiative focuses on better surveillance, increasing antivenom availability, and improving public awareness.

However, experts suggest that further action is crucial to address the persistent neglect surrounding snakebite fatalities, which are perceived as a problem primarily affecting the impoverished.

Inconsistencies in the implementation of healthcare initiatives highlight the urgent need for a systemic overhaul to ensure timely access to treatment for victims of snakebites, particularly in rural regions where road conditions and transport services are severely lacking.

}